Synthesis and biological evaluation of new sulfonamide derivatives as potential anti-Trypanosoma cruzi agents

Medicinal Chemistry

Volumn 8, Issue 6, 2012, Pages 1039-1044

  Bocanegra Garcia, Virgilio ^a   Villalobos Rocha, Juan Carlos ^a   Nogueda Torres, Benjamín ^a   Lemus Hernandez, María Edith ^b   Camargo Ordoñez, Argelia ^b   Rosas Garcia, Ninfa Maria ^a   Rivera, Gildardo ^a  

^a INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^b UNIVERSIDAD AUTÓNOMA DE TAMAULIPAS   (Mexico)

Author keywords

Biological Activity; Chagas; Sulfonamide; Sulfonamidoquinoline; Synthesis; Trypanosoma Cruzi

Indexed keywords

2 METHYL 4 QUINOLINAMINE; 4 NITRO N (4 CHLORO PHENYL) BENZENESULFONAMIDE; ANTITRYPANOSOMAL AGENT; BENZNIDAZOLE; N (1H BENZIMIDAZOL 2 YL) BENZENESULFONAMIDE; N (1H BENZIMIDAZOL 2 YL) BIPHENYL 4 SULFONAMIDE; N (2 HYDROXY PHENYLCARBONYL) BIPHENYL 4 SULFONAMIDE; N (2 METHYL QUINOLIN 4 YL) 2 FUROYL AMIDE; N (2 METHYL QUINOLIN 4 YL) 4 METHYL BENZENESULFONAMIDE; N (2 METHYL QUINOLIN 4 YL) BENZENESULFONAMIDE; N (2 METHYL QUINOLIN 4 YL) BIPHENYL 4 SULFONAMIDE; N (BENZENESULFONYL) BIPHENYL 4 SULFONAMIDE; N (BIPHENYL 4 YL SULFONYL) NICOTINAMIDE; N (PHENYLCARBONYL) BENZENESULFONAMIDE; NIFURTIMOX; P 001; P 002; P 003; P 004; P 005; P 006; P 007; P 008; P 009; P 010; P 011; P 012; SULFONAMIDE; SULFONAMIDOQUINOINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIPROTOZOAL ACTIVITY; ARTICLE; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; HYDROGEN BOND; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; STRUCTURE ACTIVITY RELATION; TRYPANOSOMA CRUZI;

ANIMALS; CHEMISTRY TECHNIQUES, SYNTHETIC; INHIBITORY CONCENTRATION 50; MICE; SPECIES SPECIFICITY; SULFONAMIDES; TRYPANOCIDAL AGENTS; TRYPANOSOMA CRUZI;

EID: 84868022288     PISSN: 15734064     EISSN: 18756638     Source Type: Journal    
DOI: 10.2174/1573406411208061039     Document Type: Article

References (26)

1. Lescure, F.X.; Canestri, A.; Melliez, H.; Jauréguiberry, S.; Develoux, M.; Dorent, R.; Guiard-Schmid, J.B.; Bonnard, P.; Ajana, F.; Rolla, V.; Carlier, Y.; Gay, F.; Elghouzzi, M.H.; Danis, M.; Pialoux, G. Chagas disease, France. Emerg. Infect. Dis., 2008, 14(4), 644-646.
2. Bargues, M.D.; Marcilla, A.; Dujardin, J.P.; Mas-Coma, S. Triatomine vectors of Trypanosoma cruzi: a molecular perspective based on nuclear ribosomal DNA markers. Trans. R. Soc. Trop. Med. Hyg., 2002, 96(Suppl 1), S159-164.
3. World Health Organization Control of Chagas disease Tech. Rep. Ser., 2002, 905, 1.
4. Wilkinson, S.R.; Taylor, M.C.; Horn, D.; Kelly, J.M.; Cheeseman, I. A mechanism for cross-resistance to nifurtimox and beznidazole in trypanosomes. Proc. Natl. Acad. Sci. USA, 2008, 105(13), 5022-5027.
5. Roush, W.R.; Cheng, J.; Knapp-Reed, B.; Alvarez-Hernandez, A.; McKerrow, J.H.; Hansell, E.; Engel, J.C. Potent second generation vinyl sulfonamide inhibitors of the trypanosomal cysteine protease cruzain. Bioorg. Med. Chem. Lett., 2001, 11(20), 2759-2762.
6. Kim, J.H.; Ryu, H.W.; Shim, J.H.; Park, K.H.; Withers, S.G. Development of new and selective Trypanosoma cruzi trans-sialidase inhibitors from sulfonamide chalcones and their derivatives. Chembiochem., 2009, 10(15), 2475-2479.
7. Nakayama, H.; Ferreira, M.E.; Rojas de Arias, A.; Vera de Bilbao, N.; Torres, S.; Schinini, A; Fournet, A. Experimental treatment of Chronic Trypanosoma cruzi infection in mice with 2-Npropilquinoline. Pytother. Res., 2001, 15(7), 630-632.
8. Fakhfakh, MA.; Fournet, A.; Prina, E.; Mouscadet, JF.; Franck, X.; Hocquemiller, R.; Figadere, B. Synthesis and Biological evaluation of substituted quinolones: potential treatement of protozoal and retroviral co-infections. Bioorg. Med. Chem., 2003, 11, 5013-5023.
9. Muscia, G.C.; Bollini, M.; Carnevale, J.P.; Bruno, A.M.; Asis S.E. Microwave-assisted Friedländer synthesis of quinolines derivatives as potential antiparasitic agents. Tetrahedron, 2006, 47(50), 8811-8815.
10. Fotie, J.; Kaiser, M.; Delfín, D.A.; Manley, J.; Reid, C.S.; Paris, J.M.; Wenzler, T.; Maes, L.; Mahasenan, K.V.; Li, C.; Werbovetz, K.A. Antitrypanosomal activity of 1,2-dihydroquinolin-6-ols and their ester derivatives. J. Med. Chem., 2010, 53(3), 966-982.
11. da Silva, L.E.; Joussef A.C.; Pacheco, LK.; da Silva, D.G.; Steindel, M.; Rebelo R.A. Synthesis and in vitro evaluation of leishmanicidal and trypanocidal activities of N-quinolin-8-ylarylsulfonamides. Bioorg. Med. Chem., 2007, 15(24), 7553-7560.
12. Pagliero, R.J.; Lusvarghi, S.; Pierini, A.B.; Brun, R.; Mazzieri, MR. Synthesis, stereoelectronic characterization and antiparasitic activity of new 1-benzenesulfonyl-2-methyl-1,2,3,4- tetrahydroquino-lines. Bioorg. Med. Chem., 2010, 18(1), 142-150.
13. Moreira, D.R.; Leite, A.C.; dos Santos, R. R.; Soares, M. B. Approaches for the Development of New Anti-Trypanosoma cruzi Agents. Curr. Drug Targets., 2009, 10, 212-231.
14. Cirauqui, N.; Ceras, J.; Galiano, S.; Perez-Silanes, S.; Juanenea, L.; Rivera, G.; Aldana, I.; Monge, A. New amide derivatives as melanin- concentrating hormone receptor 1 antagonists for the treatment of obesity. Arzneimittelforschung, 2008, 58(11), 585-591.
15. Camargo-Ordoñez, A.; Moreno-Reyes, C.; Olazarán- Santibáñez, F.; Martínez-Hernández, S.; Bocanegra-García, V.; Rivera, G. Efficient synthesis of sulfonamide derivatives on solid supports catalyzed using solvent-free and microwave-assisted methods. Química Nova, 2011, 34(5), 787-791.
16. Oliveira, R.B.; Passos, A.P.; Alves R.O.; Romanha, A.J.; Prado, M.A.; de Souza Filho, J.D.; Alves R.J. In vitro evaluation of the activity of aromatic nitrocompounds against Trypanosoma cruzi. Mem. Inst. Oswaldo Cruz., 2003, 98(1), 141-144.
17. Brener, Z. Therapeutic activity and criterion of cure on mice experimentally infected with Trypomastigote cruzi. Rev. Inst. Med. Trop. Sao Paulo., 1962, 4, 389-396.
18. Boiani, M.; Boiani, L.; Merlino, A.; Hernández, P.; Chidichimo, A.; Cazzulo, J.J.; Cerecetto, H.; González, M. Second generation of 2H-benzimidazole 1,3-dioxide derivatives as anti-trypanosomatid agents: synthesis, biological evaluation, and mode of action studies. Eur. J. Med. Chem., 2009, 44(11), 4426-4433.
19. Alvarez-Lueje, A.; Zapata-Urzúa, C.; Brain-Isasi, S.; Pérez-Ortiz, M.; Barros, L.; Pessoa-Mahana, H.; Kogan, M.J. Electrochemical study and analytical applications for new biologically active 2- nitrophenylbenzimidazole derivatives. Talanta., 2009, 79(3), 687-694.
20. Boiani. M.; Boiani, L.; Denicola, A.; Torres de Ortiz, S.; Serna, E.; Vera de Bilbao, N.; Sanabria, L.; Yaluff, G.; Nakayama, H.; Rojas de Arias, A.; Vega, C.; Rolan, M.; Gómez-Barrio, A.; Cerecetto, H.; González, M. 2H-benzimidazole 1,3-dioxide derivatives: a new family of water-soluble anti-trypanosomatid agents. J. Med. Chem., 2006, 49(11), 3215-24.
21. Aguirre, G.; Boiani, M.; Cerecetto, H.; Gerpe, A.; González, M.; Sainz, Y.F.; Denicola, A.; De Ocáriz, C.O.; Nogal, J.J.; Montero, D.; Escario, J.A. Novel antiprotozoal products: imidazole and benzimidazole N-oxide derivatives and related compounds. Arch. Pharm. (Weinheim.), 2004, 337(5), 259-270.
22. Romeiro, N.C.; Aguirre, G.; Hernández, P.; González, M.; Cerecetto, H.; Aldana, I.; Pérez-Silanes, S.; Monge, A.; Barreiro, E.J.; Lima, L.M. Synthesis, trypanocidal activity and docking studies of novel quinoxaline-N-acylhydrazones, designed as cruzain inhibitors candidates. Bioorg. Med. Chem., 2009, 17(2), 641-652.
23. Leite, A.C.; Moreira, D.R.; Cardoso, M.V.; Hernandes, M.Z.; Alves- Pereira, V.R.; Silva, R.O.; Kiperstok, A.C.; Lima, M.S.; Soares, M.B. Synthesis, Cruzain docking, and in vitro studies of aryl-4- oxothiazolylhydrazones against Trypanosoma cruzi. ChemMed- Chem., 2007, 2(9), 1339-1345.
24. dos Santos Filho, J.M.; Leite, A.C.; de Oliveira, B.G.; Moreira, D.R.; Lima, M.S.; Soares, M.B.; Leite, L.F. Design, synthesis and cruzain docking of 3-(4-substituted-aryl)-1,2,4-oxadiazole-Nacylhydrazones as anti-Trypanosoma cruzi agents. Bioorg. Med. Chem., 2009, 17(18), 6682-6691.
25. Olea-Azar, C.; Rigol, C.; Mendizabal, F.; Morello, A.; Maya, J.D.; Moncada, C.; Cabrera, E.; Di Maio, R.; González, M.; Cerecetto, H. ESR spin trapping studies of free radicals generated from nitrofuran derivative analogues of nifurtimox by electrochemical and Trypanosoma cruzi reduction. Free Radic. Res., 2003, 37(9), 993-1001.
26. Maya, J.D.; Bollo, S.; Nuñez-Vergara, L.J.; Squella, J.A.; Repetto, Y.; Morello, A.; Périé, J.; Chauvière, G. Trypanosoma cruzi: effect and mode of action of nitroimidazole and nitrofuran derivatives. Biochem. Pharmacol., 2003, 65(6), 999-1006.